Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 3 20Phase 1 16Phase 1/2 6Phase NA 2Phase 2/3 1

Status

Unknown 3Recruiting 3Completed 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Thromboembolism 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Standard of Care 40Methods 37Exercise 36Educational Status 36Practice Guidelines as Topic 35Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 25Magnetic Resonance Spectroscopy 23Interviews as Topic 21Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Palliative Care 12Counseling 12Radiation 11Nutrition Assessment 11Specimen Handling 10Resistance Training 10Proton Therapy 8Mammography 8Biopsy 8Radiofrequency Ablation 7Exercise Test 7Drug Therapy 7Diet Therapy 7Control Groups 7Yoga 6X-Rays 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × 130-nm albumin-bound paclitaxel × Clear all
NCT05407155 2026-04-23

BETTER

Fudan University

Phase NA Active not recruiting
56 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
110 enrolled
Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡